Arumugam Manoharan
Northfields Ave
Wollongong, NSW 2522, Australia
Wollongong, NSW 2522, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Regression of Post-Essential Thrombocythaemia Myelofibrosis with Intermittent Hydroxyurea Therapy: A Case Report.
Journal: Journal of clinical medicine
Published: October 12, 2025
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.
Journal: Journal of clinical medicine
Published: June 23, 2024
Regression of Intermediate-High Risk Monoclonal Gammopathy of Undetermined Significance (MGUS) With Long-term Use of Curcumin: A Case Report.
Journal: Integrative cancer therapies
Published: March 26, 2024
Insights into the Impact of Hesitancy on Cancer Care and COVID-19.
Journal: Cancers
Published: April 08, 2023
Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma.
Journal: Journal of hematology
Published: March 15, 2023
Polyphenol-Rich Ginger (Zingiber officinale) for Iron Deficiency Anaemia and Other Clinical Entities Associated with Altered Iron Metabolism.
Journal: Molecules (Basel, Switzerland)
Published: July 31, 2022
Thrombosis in Myeloproliferative Neoplasms: A Single Center Experience of Using Whole Blood Platelet Aggregation Studies for Risk Assessment and Thromboprophylaxis.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: July 28, 2022
Primary immune thrombocytopenia: a 'diagnosis of exclusion'?
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: July 22, 2022
Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review.
Journal: Integrative cancer therapies
Published: December 21, 2021
Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study.
Journal: Journal of hematology
Published: May 19, 2020
Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot study.
Journal: American journal of hematology
Published: May 11, 2020
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy.
Journal: Clinical case reports
Published: August 28, 2019
Last Updated: 09/26/2026